- Home
- COOK vs RNAC Comparison
COOK vs RNAC Comparison
Compare COOK & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- RNAC
- Stock Information
- Founded
- COOK 1985
- RNAC 2007
- Country
- COOK United States
- RNAC United States
- Employees
- COOK N/A
- RNAC N/A
- Industry
- COOK Wholesale Distributors
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- RNAC Health Care
- Exchange
- COOK Nasdaq
- RNAC Nasdaq
- Market Cap
- COOK 255.1M
- RNAC 282.6M
- IPO Year
- COOK 2021
- RNAC 2016
- Fundamental
- Price
- COOK $1.90
- RNAC $12.30
- Analyst Decision
- COOK Buy
- RNAC Strong Buy
- Analyst Count
- COOK 7
- RNAC 5
- Target Price
- COOK $2.43
- RNAC $40.00
- AVG Volume (30 Days)
- COOK 287.3K
- RNAC 84.2K
- Earning Date
- COOK 08-05-2025
- RNAC 08-07-2025
- Dividend Yield
- COOK N/A
- RNAC N/A
- EPS Growth
- COOK N/A
- RNAC N/A
- EPS
- COOK N/A
- RNAC N/A
- Revenue
- COOK $602,441,000.00
- RNAC $34,173,000.00
- Revenue This Year
- COOK $0.06
- RNAC N/A
- Revenue Next Year
- COOK $3.18
- RNAC N/A
- P/E Ratio
- COOK N/A
- RNAC N/A
- Revenue Growth
- COOK 0.80
- RNAC 31.91
- 52 Week Low
- COOK $1.28
- RNAC $8.46
- 52 Week High
- COOK $3.97
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- COOK 59.14
- RNAC 56.24
- Support Level
- COOK $1.91
- RNAC $12.50
- Resistance Level
- COOK $2.08
- RNAC $13.80
- Average True Range (ATR)
- COOK 0.11
- RNAC 0.95
- MACD
- COOK -0.00
- RNAC 0.09
- Stochastic Oscillator
- COOK 70.73
- RNAC 42.02
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.